THURSDAY, SEPTEMBER 5, 2024
7:00 am - 8:00 am
CONTINENTAL BREAKFAST
Morning accredited CME programming commences.
8:00 am - 8:15 am
INTRODUCTION & WELCOME
8:15 am - 9:35 am
SCIENTIFIC SESSION I: Stones / Endourology
(5 minute presentation, 3 minute discussion)
Moderators: Peter Steinberg, MD, Piruz Motamedinia, MD
Patient Experience with Tria versus Traditional Ureteral Stents
Daniel Pohl, MD
1, Jessica Mandeville, MD
1, Yixin Kong, PhD
1, Laken Smothers, MPH, BS
2, William Faust, MD
1
1Lahey Clinic and Medical Center, Burlington, MA, USA, 2Tufts University School of Medicine, Boston, MA, USA
Assessing the safety of ureteral stent placement for obstructive urolithiasis in patients during the covid-19 pandemic
Ankur Ushir Choksi, MD, Soum D. Lokeshwar, MD, Mursal Gardezi, MD, Christopher S. Hayden, MD, Timothy Tran, MD, Dinesh Singh, MD, Piruz Motamedinia, MD, Thomas V. Martin, MD.
Yale School of Medicine, New Haven, CT, USA.
Regional Trends in Potassium Citrate Prescribing Amongst Urologists in the United States
Emma Harwood, MD
1, Evelyn James, MPH
1, Daniel Wollin, MS, MD
2, David Sobel, MD
1
1Maine Medical Center, Portland, ME, USA, 2Brigham and Women’s Hospital, Boston, MA, USA
Pharmacovigilance Study of Type 1a Selective Alpha Blocker Side Effects in Nephrolithiasis
Jonathan J. Song, BA
1, Quoc-Dien Trinh, MD, MBA
2, Daniel A. Wollin, MD
3
1Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA, 2Department of Urology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA, 3Department of Urology, Brigham and Women’s Hospital, Boston, MA, USA
Initial Experience with Single-Port Robot-Assisted Partial Nephrectomy: A Comparison with Multi-Port Partial Nephrectomy
Angela Estevez, MD, Helen W. Cui, BMBS PhD, Gabriela Nieto-Blanco, MS, Jeffrey Sun, BS, Sarah Duncan, BA, Phillip Kim, MD, Adam Nolte, MD, Peter Chang, MD MPH, Andrew A. Wagner, MD
Beth Israel Deaconess Medical Center, Boston, MA, USA
Single-Probe Dual-Energy Lithotripter Complications: A Law Review and Comprehensive Analysis of the FDA MAUDE Database
Cedrick B. Chiu, BS
1, Orleiquis Guerra, MD
1, Clemens An, BS
2, Kevan Sternberg, MD
1
1UMass Chan Medical School, Worcester, MA, USA, 2Larner College of Medicine at The University of Vermont, Burlington, VT, USA
Prolonged Antibiotic Exposure Within 90 Days of Percutaneous Nephrolithotomy is Not a Risk Factor for Yeast Growth in Renal Stone Culture
Fern Calkins, B.S.
1, Architha Sudhakar, MD
2, Evelyn James, M.S.
2, Erin Santos, PA-C
2, David W. Sobel, MD
2
1Tufts University School of Medicine, Boston, MA, USA, 2Division of Urology, Maine Medical Center, Portland, ME, USA
Ureteral Stricture Formation After Use of Ureteral Access Sheaths
Christina Kottooran, MD
1, Jose ECM Rodrigues, MD
2, Brian H. Eisner, MD
1.
1Massachusetts General Hospital, Boston, MA, USA, 2Universidade de São Paulo, São Paulo, Brazil.
Senior Slump? The Arc of Ureteroscopy Experience and Trainee Confidence During Residency Training
Loren J. Smith, MD
1, Evelyn James, MPH
1, Vanessa Lukas, MD
2, Kevan Sternberg, MD
3, Daniel Wollin, MD
2, David Sobel, MD
1
1Division of Urologic Surgery, Maine Medical Center, Portland, ME, USA, 2Department of Urology, Brigham and Women's Hospital, Boston, MA, USA, 3University of Massachusetts Memorial Medical Center, Worcester, MA, USA
9:35 am - 10:00 am
COFFEE BREAK
10:00 am - 10:30 am
STATE OF THE ART LECTURE I: Kidney Cancer, Unmasking the Myths
Alexander Kutikov, MD, FACS
Fox Chase Cancer Center, Philadelphia, PA
10:30 am - 11:00 am
PANEL: New Technologies in Urology
FPRMS: Sanchita Bose, MD
Endourology: Ruslan Korets, MD
Men’s Health: Gabby Avellino, MD
Reconstructive Urology: Marissa Kent, MD
11:00 am - 12:30 pm
SCIENTIFIC SESSION II: Prostate Cancer I
(5 minute presentation, 3 minute discussion)
Moderators: Keyan Salari, MD, Joseph Brito, MD
A Propensity Score Matched Analysis Of Apical Margin Positivity Between Single Port And Multiple Port Robotic Radical Prostatectomies
Ankur Ushir Choksi, MD, Soum D. Lokeshwar, MD, Joseph Renzulli, MD, Joseph Brito, MD, David Hesse, MD, Thomas V. Martin, MD, Preston Sprenkle, MD, Michael Leapman, MD, Isaac Y. Kim, MD PhD MBA
Yale School of Medicine, New Haven, CT, USA
Comparison Of The Incidence Of Clinically Significant Prostate Cancer In Patients With Isolated Peripheral Vs Transitional Zone PIRADS 3 Lesions
Kamil Malshy, MD
1, Anna Ochsner, B.Sc
2, Rebecca Ortiz, B.Sc
1, Benjamin Ahn, B.Sc
2, Richard Glebocki, B.Sc
1, Mathew Liu, Mr.
1, Borivoj Golijanin, MD
1, Samuel Eaton, MD
1, Dragan Golijanin, MD
1, Elias Hyams, MD
1, Sari Khaleel, MD
1
1Minimally Invasive Urology Institute, The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA, 2Warren Alpert Medical School of Brown University, Providence, RI, USA
Conditional Survival Over Time and Time-Varying Analysis on Active Surveillance for Prostate Cancer
Hersh H. Bendre, MD, Florian Rumpf, MD, Andrew Gusev, MD, Alie Hunter, BA, Aileen Feng, BA, Neel Patel, MBBS, Matthew Wszolek, MD, Douglas Dahl, MD, Adam Feldman, MD, MPH, Keyan Salari, MD, PhD
Massachusetts General Hospital, Boston, MA, USA
Traditional Racial and Sociodemographic Disparities in Prostate Cancer Screening are not Evident in a Large Public Safety-Net Institution
Hanna Zurl, MD
1, Michelle Shabo, MD
2, Filippo Dagnino, MD
1, Rumel Mahmood, PhD
3, Benjamin G. Allar, MD MPH
4, Boris Gershman, MD
2, Lisa Weissman, MD
5, Gezzer Ortega, MD MPH
6, Stephanie Hastings, DO
7, Heidi J. Rayala, MD PhD
2
1Department of Urology, Brigham and Women’s Hospital and Center for Surgery and Public Health, Harvard Medical School, Boston, MA, USA, 2Division of Urology, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA, 3Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, USA, 4Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA, 5Department of Hematology/Oncology, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, USA, 6Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA, 7Department of Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, USA
The Use of Multiparametric MRI and Fusion Biopsy in Active Surveillance Results in Earlier Identification and Treatment of Clinically Significant Prostate Cancer
Christina Kottooran, MD
1, Hersh Bendre, MD
1, Alice Yu, MD
2, Andrew Gusev, MD
1, Timothy Baloda, MD
3, Eduoard Nicaise, MD
4, Mukesh Harisinghani, MD
1, Amirkasra Mojtahed, MD
1, Anthony Zietman, MD
1, Douglas M. Dahl, MD
1, Matthew Wszolek, MD
1, Keyan Salari, MD, PhD
1, Adam Feldman, MD, MPH
1
1Massachusetts General Hospital, Boston, MA, USA, 2Moffitt Cancer Center, Tampa, FL, USA, 3Emory Healthcare, Atlanta, GA, USA, 4Lenox Hill Hospital, New York, NY, USA
Time Trends and Determinants of Active Surveillance Among Patients with Intermediate Risk Prostate Cancer
Ismail Ajjawi, MD, Vinaik Sundaresan, MD, Shayan Smani, MD, Preston C. Sprenkle, MD, Michael S. Leapman, MD, MHS
Yale School of Medicine, New Haven, CT, USA
Retrospective Comparison Between Transperineal and Transrectal Prostate Biopsy Complications
Alfred A. Barney, IV, B.S.
1, Piroz Bahar, B.S.
2, Constantine Velmahos, B.S.
3, Clemens An, B.S.
4, Aileen Feng, B.S.
1, Shulin Wu, MD
1, Chin-Lee Wu, MD, Ph.D
1, Michelle Kim, MD, Ph.D
1, Douglas M. Dahl, MD
1, Adam S. Feldman, MD, MPH
1
1Massachusetts General Hospital, Boston, MA, USA, 2University of Michigan Medical School, Ann Arbor, MI, USA, 3University of Massachusetts Chan Medical School, Worcester, MA, USA, 4Larner College of Medicine, University of Vermont, Burlington, VT, USA
Racial Differences in Post-Pandemic Trends in Prostate Specific Antigen Screening
Zhiyu (Jason) Qian, MD, Jameshisa Alexander, BS, Danesha Daniels, BS, Firas Abdollah, MD, Alexander P. Cole, MD, Hari Iyer, ScD, Quoc-Dien Trinh, MD, MBA
Brigham and Women's Hospital, Boston, MA, USA
Outcomes Of Men With High-Risk Biochemically Recurrent Prostate Cancer Who Suspended Enzalutamide Monotherapy Treatment In The Phase 3 EMBARK Study
Neal D. Shore, MD, FACS
1, Paul R. Sieber, MD
2, Ugo De Giorgi, MD, PhD
3, Tony Luongo, MD
4, Bryan A. Mehlhaff, MD
5, Daniel C. Danila, MD
6, Curtis J. Dunshee, MD, FACS
7, Costas D. Lallas, MD
8, Marc J. Pliskin, MD
9, Yiyun Tang, PhD
10, Gabriel P. Haas, MD, FACS
11, Matt Rosales, PhD
11, Jamal Tarazi, MD, MPA
12, Fabian Zohren, MD, PhD
12, David Russell, MD
10, Stephen J. Freedland, MD
13
1Surgical Oncology and Urology, Carolina Urologic Research Center, Myrtle Beach, SC, USA, 2Keystone Urology Specialists, Lancaster, PA, USA, 3IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy, 4Tufts University School of Medicine, Boston, MA, USA, 5Oregon Urology Institute, Springfield, OR, USA, 6Memorial Sloan Kettering, New York, NY, USA, 7Urological Associates of Southern Arizona, Tucson, AZ, USA, 8Jefferson Urology Associates, Philadelphia, PA, USA, 9TriState Urologic Services PSC Inc., dba The Urology Group, Cincinnati, OH, USA, 10Pfizer Inc., New York, NY, USA, 11Global Product Development, Astellas Pharma Inc., Northbrook, IL, USA, 12Formerly of Pfizer Inc., New York, NY, USA, 13Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA and the Durham VA Medical Center, Durham, NC, USA
Need For Combined Targeted And Systematic Biopsy In Detection Of Clinically Significant Prostate Cancer
Anna M. Ochsner, BS, Kamil Malshy, MD, Rebecca Ortiz, BS, Borivoj Golijanin, BS, Benjamin Ahn, BS, Richard Glebocki, BS, Matthew Liu, BS, Sari Khaleel, MD, Dragan Golijanin, MD, Elias Hyams, MD
Minimally Invasive Urology Institute, Providence, RI, USA
Risk factors for Gleason Upgrading: A Comparison of High-resolution Micro-Ultrasound, Conventional Ultrasound and MRI fusion Biopsy Techniques
Soum D. Lokeshwar, MD, MBA, Ankur U. Choksi, MD, Shayan Smani, BS, Victoria Kong, BS, Vinaik Sundaresan, BS, Joseph Brito, MD, Joseph Renzulli, MD, Preston Sprenkle, MD, Michael S. Leapman, MD MHS
Yale University, New Haven, CT, USA
Conclusion of morning accredited CME programming.
12:30 pm - 12:40 pm
AUA POLITICAL ACTION COMMITTEE (PAC) UPDATE
Arthur Tarantino, MD
12:40 pm - 12:50 pm
AUA STATE ADVOCACY COMMITTEE (SAC) UPDATE
Brian Irwin, MD
12:50 pm - 1:00 pm
PUBLIC POLICY COUNCIL UPDATE
Jen Yates, MD
1:00 pm - 2:00 pm
LUNCH SYMPOSIUM
A GnRH Antagonist Treatment Option for Advanced Prostate Cancer
Sponsored by Sumitomo/Pfizer Pharma
Speaker: Christopher M. Pieczonka, MD
1:00 pm - 2:00 pm
LUNCH SYMPOSIUM
Initial and Updated Clinical Data for Certain Patients With RCC in the Adjuvant Setting
Sponsored by Merck
Speaker: Paul Sieber, MD
2:00 pm - 2:15 pm
AMERICAN BOARD OF UROLOGY UPDATE
Ann Gormley, MD
2:15 pm - 2:30 pm
JU UPDATE
Martin Gross, MD
Afternoon accredited CME programming commences.
2:30 pm - 3:30 pm
CONCURRENT POSTER SESSION I
(3-minute presentation, 2-minute discussion)
Moderators: Michael Grant, MD, Lauren Bakios, MD
Methylation of SRD5A2 in the Blood as a Novel Biomarker to Predict Sensitivity to 5-ARI Treatment
Ra'ad Al-Faouri, MD MMSc
1, Christina Sharkey, ALM
1, Heidi Rayala, MD, PHD
1, Ruslan Korets, MD
1, Wei Wang, PHD
2, Zongwei Wang, PHD
1, Mukesh G. Harisinghani, MD
3, Leo L. Tsai, MD, PHD
3, Aria F. Olumi, MD
1
1Beth Israel Deaconess Medical Center - Harvard Medical School, Boston, MA, USA, 2Brigham and Women's Hospital - Harvard Medical School, Boston, MA, USA, 3Massachusetts General Hospital - Harvard Medical School, Boston, MA, USA
Advancing Minimally Invasive Adrenalectomy: Is There a Benefit of the Robotic-Assisted Single Port Approach?
Angela Estevez, MD, Helen W. Cui, BMBS PhD, Phillip Kim, MD, Adam Nolte, MD, Gabriela Nieto-Blanco, M.S, Jeffrey Sun, B.S, Sarah Duncan, BA, Peter Chang, MD MPH, Andrew A. Wagner, MD
Beth Israel Deaconess Medical Center, Boston, MA, USA
Evaluating Factors Affecting the Recurrence of Testicular Torsion in a Single New England State
Jacqueline Klepinger, BS
1, Loren Smith, MD
1, Evelyn James, MPH
2, Lily Wang, MD-PhD
1
1Maine Medical Center, Portland, ME, USA, 2Maine Medical Partners, South Portland, ME, USA
Factors Associated with Outcomes after Pyeloplasty in the Pediatric Population
Olamide Olawoyin, MD, Benjamin Press, MD, Ankur U. Choksi, MD, Robert M. Weiss, MD, FACS, FAAP, Joshua Sterling, MD, MSc, Angela Arlen, MD
Yale New Haven Health, New Haven, VT, USA
The Association of Robotic-Assisted versus Open Radical Cystectomy with Real-World Postoperative Morbidity among Older Adults With Bladder Cancer
Joseph B. Black, MD, PHD
1, Sumedh Kaul, MS
1, Aaron Fleishman, MPH
1, Ruslan Korets, MD
1, Peter Chang, MD, MPH
1, Andrew Wagner, MD
1, Simon Kim, MD
2, Joaquim Bellmunt, MD, PHD
3, Nima Aghdam, MD
1, Irving Kaplan, MD
1, Aria F. Olumi, MD
1, Boris Gershman, MD
1
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2University of Colorado Anschutz Medical Center, Aurora, CO, USA, 3Dana-Farber Cancer Institute, Boston, MA, USA
Evaluating the Surgical Goals of Transgender Male versus Non-Binary Individuals Considering Metoidioplasty and Phalloplasty Gender Affirming Surgery (MaPGAS)
Lee K. Brown, BA
1, Linda M. Kinney, MPA
2, Rebecca L. Butcher, MS, MPH
2, Rachel A. Moses, MD, MPH
1
1Dartmouth-Hitchcock Clinic, Lebanon, NH, USA, 2The Center for Program Design and Evaluation (CPDE), The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA
Gender Disparities in Urology Top Doctor Selection
Anna Saltman, MD, MS, Rachel Mann, MD, Lara MacLachlan, MD, Alireza Moinzadeh, MD, Jessica Mandeville, MD
Lahey, Burlington, MA, USA
Bowel Function after Cystectomy - Does Anything Even Matter?
Randie E. White, MD
1, Connor Pelletier, BS
2, Evelyn James, BA, MPH
1, Joshua Linscott, MD, PhD
3, Jeffrey M. Howard, MD, PhD
1, Stephen T. Ryan, MD
1, Matthew H. Hayn, MD
1, Jesse D. Sammon, DO
1
1Maine Medical Center, PORTLAND, ME, USA, 2University of New England School of Osteopathic Medicine, Biddeford, ME, USA, 3Moffitt Cancer Center, Tampa, FL, USA
Progression on Active Surveillance is Low in Men with PSA Density <0.15 Or Absence of Cancer in MRI-Identified Lesions
Lindsey T. Webb, BSME, Nethusan Sivanesen, BS, BA, Gabriela M. Diaz, MD, Syed N. Rahman, MD, Ghazal Khajir, MD, Preston C. Sprenkle, MD
Yale School of Medicine, New Haven, CT, USA
Assessing the Deliverables of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Transperineal Prostate Biopsy
Dylan M. Buller, MD
1, William Martin, BS
2, Benjamin Rosenfeld, MD
2, Amanda Sherman, MD
3, William C. Faust, MD
3, Serge Ginzburg, MD
4, Joseph R. Wagner, MD
5, Andres F. Correa, MD
6, Kevin Pinto, BS
5, Peter C. Albertsen, MD
1, Alexander Kutikov, MD
6, Benjamin T. Ristau, MD, MHA
1
1UConn Health, Farmington, CT, USA, 2University of Connecticut School of Medicine, Farmington, CT, USA, 3Lahey Hospital and Medical Center, Burlington, MA, USA, 4Jefferson Einstein Hospital, Philadelphia, PA, USA, 5Hartford Healthcare Medical Group, Hartford, CT, USA, 6Fox Chase Cancer Center, Philadelphia, PA, USA
2:30 pm - 3:30 pm
CONCURRENT SCIENTIFIC SESSION III: Trauma, Recon, Female Urology and Transgender
(5 minute presentation, 3-minute discussion)
Moderators: Rachel Moses, MD, Mary Grey Maher, MD
Development of a Co-Designed Web-Based Decision Aid for Metoidioplasty and Phalloplasty Gender Affirming Surgeries
Rachel A. Moses, MD, MPH
1, Lee K. Brown, BA
1, Rebecca L. Butcher, MS, MPH
2, Linda M. Kinney, MPA
3, Gaines Blasdel, BS
4, Jeremy B. Myers, MD
5, John F. Nigriny, MD
1, Glyn Elwyn, MD, PhD, MSc
6
1Dartmouth-Hitchcock Clinic, Lebanon, NH, USA, 2The Center for Program Design and Evaluation (CPDE), The Dartmouth Institute, Geisel School of Medicine at Dartmouth College, Geisel, NH, USA, 3The Center for Program Design and Evaluation (CPDE), The Dartmouth Institute, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA, 4University of Michigan Medical School, Ann Arbor, MI, USA, 5University of Utah, Salt Lake City, UT, USA, 6The Coproduction Laboratory, The Dartmouth Institute, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA
6-Month Interim Results of a Phase 4, Real-World Study (COMPOSUR) to Evaluate Vibegron in Patients With Overactive Bladder
Michael J. Kennelly, MD
1, Roger R. Dmochowski, MD
2, Eric S. Rovner, MD
3, Diane K. Newman, DNP, ANP-BC
4, Keith Xavier, MD
5, Jingmei Lu, MS
6, Daniel Snyder, PhD
6, Laleh Abedinzadeh, MD
6
1Carolinas Medical Center, Charlotte, NC, USA, 2Vanderbilt University Medical Center, Nashville, TN, USA, 3Medical University of South Carolina, Charleston, SC, USA, 4Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, 5Urology Partners of North Texas, Arlington, TX, USA, 6Sumitomo Pharma America, Inc., Marlborough, MA, USA
Comparing Lifespan of Virgin Artificial Urinary Sphincters in Radiated Patients: Transcorporal vs. Standard Placement
Kamil Malshy, MD
1, Siddharth Marthi, MD
2, Rebecca Ortiz, B.Sc
1, Edouard Nicaise, MD
2, Borivoj Golijanin, B.Sc
1, Kennon Miller, MD
1, Lindsey Hartsell, M.D
2, Madeline Cancian, MD
1
1Minimally Invasive Urology Institute, The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA, 2Department of Urology, Emory University Hospital, Atlanta, GA, USA
Exploring Radiation Cystitis Diagnosis and Management Including Hyperbaric Oxygen Therapy: A Survey of Reconstructive Urologists Practice Patterns
Richard Hans Bellemare, MD
1, Lee K. Brown, BA
1, William Bihrle, III, MD
1, Jeremy B. Myers, MD
2, Jay C. Buckey, Jr., MD
3, Jill C. Buckley, MD
4, Rachel A. Moses, MD, MPH
1
1Dartmouth Health, Section of Urology, Department of Surgery, Lebanon, NH, USA, 2University of Utah, Division of Urology, Department of Surgery, Salt Lake City, UT, USA, 3Dartmouth Health, Section of Hyperbaric Medicine, Department of Medicine, Lebanon, NH, USA, 4UC San Diego Health, Department of Urology, San Diego, CA, USA
Comparison of Surgical Complication Rates in Combined Hysterectomy and Masculinizing Gender Affirming Bottom Surgery Versus Staged Approach: A National Analysis
Marissa Kent, MD, Oluwaseun Adebagbo, BS, John Park, PharmD, Macie Gettings, BS, Sasha Nickman, BS, Benjamin Rahmani, BS, Ryan Cauley, MD, PhD
Beth Israel Deaconess Medical Center, Boston, MA, USA
Fournier Gangrene Registry: Outcomes of a Single Center Over a Decade
Jessica DeLong, MD
1, Sean Elliott, MD
2, Ramon Virasoro, MD
3
1MultiCare Urology, Puyallup, WA, USA, 2University of Minnesota, Minneapolis, MN, USA, 3Eastern Colorado VA, Colorado Springs, CO, USA
Downregulated Genes Targeted By Microrna In Lichen Sclerosus Urethral Strictures
Samantha Freeman, MD, Rachael Gotlieb, MD, Kailey Hooper, BS, Travis Sullivan, MS, Aaron Perecman, MD, Anna Saltman, MD, Kimberly Rieger-Christ, PhD, Alex Vanni, MD
Lahey Hospital and Medical Center, Burlington, MA, USA
3:30 pm - 4:00 pm
COFFEE BREAK
4:00 pm - 4:30 pm
GUEST SPEAKER: Advanced Robotic Techniques including SP Platform
Peter Chang, MD
Beth Israel Deaconess Medical Center, Boston, MA
4:30 pm - 5:00 pm
DEBATE: Transperineal vs Transrectal Biopsy
Moderator: Bill Faust, MD
Ben Ristau, MD vs. Francis McGovern, MD
5:00 pm - 5:30 pm
GUEST SPEAKER: "Market Dynamics: Big Business Coming for Healthcare?"
Ruchika Talwar, MD
Vanderbilt University Medical Center, Nashville, TN
5:30 pm - 6:00 pm
SOCIOECONOMIC SESSION
Conclusion of afternoon accredited CME programming.
6:00 pm - 7:00 pm
WELCOME RECEPTION IN EXHIBIT HALL
FRIDAY, SEPTEMBER 6, 2024
7:00 am - 8:00 am
CONTINENTAL BREAKFAST
7:00 am - 8:00 am
BREAKFAST SYMPOSIUM
Treatment Intensification with XTANDI (Enzalutamide) for Patients with Metastatic Castration-Sensitive Prostate Cancer & Nonmetastatic Castration-Sensitive Prostate Cancer with Biochem Recurrence at High Risk for Metastasis
Sponsored by Astellas
Speaker: Gordon Brown, DO, FACOS
Urologic Surgery, Rowan University School of Osteopathic Medicine
Delaware Valley Urology; Kennedy University Hospital
Morning accredited CME programming commences.
7:30 am - 10:00 am
Learn Indications and proper preparation techniques for cystoscopy
Shireen Kirata PA-C
Acquire knowledge of step-by-step mechanical sequence for completion of diagnostic cystoscopy and cysto/stent pull
Dr. Manganiello
Become familiar with common cystoscopic findings
Dr. Zbrezny
Gain knowledge on how to roll out into AP practice
Dr. Stacy DiPerna ACNP
10:00 am - 10:30 am
Pelvic Floor and So Much More
Jill Cramp, PT, DPT, PRPC
8:00 am - 9:00 am
CONCURRENT SCIENTIFIC SESSION IV: General/BPH
(5 minute presentation, 3 minute discussion)
Moderators: Heidi Rayala, MD, Michael Grant, MD
Bladder Function and Safety of Vibegron in Men With Symptoms of Overactive Bladder and Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial
Eric Rovner, MD
1, Janet Owens-Grillo, PhD, MS
2, Elizabeth Thomas, MS
2, Sender Herschorn, MD
3, Kenneth Peters, MD
4, David Staskin, MD
5, Kevin Cline, MD
6, Salim Mujais, MD
2.
1Medical University of South Carolina, Charleston, SC, USA, 2Sumitomo Pharma America, Inc., Marlborough, MA, USA, 3Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada, 4Oakland University William Beaumont School of Medicine, Rochester, MI, USA, 5Tufts University School of Medicine, Boston, MA, USA, 6Louisiana State University Health, Shreveport, LA, USA
An Analysis of Reoperations for Benign Prostatic Hyperplasia from a Near Real Time Live Dataset- TriNetX
Clemens An, BS
1, Benjamin Rubin, BS
1, Jake Jeong, BS
2, Richard Grunert, MD FACS
1
1University Of Vermont, Burlington, VT, USA, 2Washington University School of Medicine, St. Louis, MO, USA
Review of an Acute Care Urology Model at a Large Tertiary Academic Medical Center
Akshay G. Reddy, MD, Jeffrey S. Lamont, MD, Michelle Kim, MD, PhD, Marc D. Manganiello, MD
Massachusetts General Hospital, Boston, MA, USA
Medication-Induced Acute Urinary Retention: Insights from FDA Pharmacovigilance Database
Cedrick B. Chiu, BS
1, Orleiquis Guerra, MD
1, Jennifer Anger, MD, MPH
2, Kevan Sternberg, MD
1
1UMass Chan Medical School, Worcester, MA, USA, 2UC San Diego Medical Center, La Jolla, CA, USA
Can Artificial Intelligence Promote Equity in Urologic Care?
Loren J. Smith, MD, Evelyn James, MPH, Bruce T. Ndebanje, B.S., Lily C. Wang, MD, PhD
Division of Urologic Surgery, Maine Medical Center, Portland, ME, USA
Does Urine Culture Before Endoscopic Prostate Surgery Decrease Postoperative Urinary Tract Infection? An Analysis of the Veterans Affairs Surgical Quality Improvement Program
Muhieddine Labban, MD
1, William J. O'Brien, MS
2, Kalpana Gupta, MD, MPH
2, Lori Lerner, MD
2
1Brigham and Women's Hospital, Boston, MA, USA, 2Veteran Affairs Boston Healthcare System, Boston, MA, USA
Diagnostic Features and Management Outcomes of Torsion-Detorsion
Olamide Olawoyin, MD, Ankur Choksi, MD, Nishan Sohoni, BSc, Benjamin Press, MD, Angela Arlen, MD
Yale New Haven Health, New Haven, CT, USA
9:00 am - 10:30 am
VIDEO ABSTRACT SESSION
(5 Minutes Videos, 4 Minute Discussion)
Moderators: Andrew Wagner, MD, Jennifer Fantasia, MD
Low Anterior Access for Retroperitoneal Single-Port Robotic Pyeloplasty
Angela Estevez, MD, Phillip Kim, MD, Suprita Krishna, MD, Helen W. Cui, BMBS PhD, Gabriela Nieto-Blanco, MS, Jeffrey Sun, BS, Sarah Duncan, BA, Adam Nolte, MD, Andrew A. Wagner, MD, Peter Chang, MD MPH
Beth Israel Deaconess Medical Center, Boston, MA, USA
View Video
Single Port Robotic Assisted Adrenalectomy - Is It Worth It?
Helen W. Cui, BMBS PhD, Angela Estevez, MD, Jeffrey Sun, Gabriela Nieto-Blanco, Phillip Kim, MD, Sarah Duncan, Adam Nolte, MD, Peter Chang, MD, Andrew A. Wagner, MD
Beth Israel Deaconess Medical Center, Boston, MA, USA
View Video
Modern Techniques to Increase Stone Free Rates
Daniela Diaz Rubayo, MD, Xinyue C. Tan, MD, Isaac Bronson, Katherine Merport, Brielle Barclay, Kevan Sternberg, MD, Igor Sorokin, MD
UMass Chan Medical School, Worcester, MA, USA
View Video
Bulkamid Injection for Recurrent Post-Prostatectomy Stress Incontinence in a Male Patient
Philip Olson, MD
1, Shanta Shepherd, MD
2
1University of Connecticut, Farmington, CT, USA, 2Saint Francis Hospital, Hartford, CT, USA
View Video
ProTouch Laser Enucleation of the Prostate (ProLEP): Procedure Video
Maya T. Zhou, BS
1, Melissa Huang
1, Evan Sheh
1, Michael Emmerling, MD
1, Wesley Pate, MD
1, Shaun E. L. Wason, MD
2
1Boston University, Boston, MA, USA, 2Beth Israel Deaconess Medical Center, Boston, MA, USA
View Video
9:00 am - 10:30 am
CONCURRENT POSTER SESSION II
(3 minute presentation, 2 minute discussion)
Moderators: Jaime Cavallo, MD, Alexander Cole, MD
Patient-reported Toxicity During Intravesical Therapy for Non-Muscle Invasive Bladder Cancer
Matthew Clements, MD, MS
1, Nicole Liso, BS
2, Benjamin Seiden, MD
3, Alvin Goh, MD
2, Timothy Donahue, MD
2, Bernard Bochner, MD
2, Eugene Pietzak, MD
2
1Lahey Hospital & Medical Center, Burlington, MA, USA, 2Memorial Sloan Kettering Cancer Center, New York, NY, USA, 3SUNY Downstate, New York, NY, USA
A Framework for Categorizing Bottom Dysphoria in Transgender and Nonbinary Patients
Hunter R. Myers, BA
1, Neeki Parsa, BA
1, Urszula Kowalik, MD
2
1Larner College of Medicine, Burlington, VT, USA, 2University of Vermont Medical Center, Burlington, VT, USA
Fournier Gangrene Registry: Outcomes of a Single Center Over a Decade
Andres H. Guillen Lozoya, MD, Luqman Ellythy, MS, Alexander Krueger, MS, Katherine Anderson, MD, Sevann Helo, MD
Mayo Clinic, Rochester, MN, USA
Exploring Urine Inflammatory Biomarkers Pre and Post Hyperbaric Oxygen Therapy for Radiation Cystitis Following Prostate Cancer: A Pilot Study
Richard Hans Bellemare, MD
1, Daniel Mielcarz, PhD
2, Ziyin Zhang, MS
3, Eugene Demidenko, PhD
4, Bassem Zaki, MD
5, William Bihrle, III, MD
1, Jay C. Buckey, Jr., MD
6, Rachel A. Moses, MD, MPH
1
1Dartmouth Health, Section of Urology, Department of Surgery, Lebanon, NH, USA, 2DartLab, Dartmouth Cancer Center, Geisel School of Medicine, Lebanon, NH, USA, 3Giesel School of Medicine at Dartmouth, Lebanon, NH, USA, 4Dartmouth Health, Dartmouth Cancer Center, Giesel School of Medicine at Dartmouth, Lebanon, NH, USA, 5Dartmouth Health, Section of Radiation Oncology, Department of Medicine, Lebanon, NH, USA, 6Dartmouth Health, Section of Hyperbaric Medicine, Department of Medicine, Lebanon, NH, USA
Timing Considerations for Artificial Urinary Sphincter Implantation Post-Pelvic Radiotherapy
Kamil Malshy, M.D
1, Siddharth Marthi, MD
2, Edouard Nicaise, MD
2, Borivoj Golijanin, MD
1, Kennon Miller, MD
1, Lindsey Hartsell, MD
2, Madeline Cancian, MD
1
1Minimally Invasive Urology Institute, The Warren Alpert Medical School of Brown University, Providence, RI, USA, 2Department of Urology, Emory University Hospital, Atlanta, GA, USA
Defining Success in Pyeloplasty Patients to Guide Initial Postoperative Followup
Jane Renee Kielhofner, BS
1, Jonathan Song, B.S.
2, Zhiyu Qian, MD
1, Catherine Gu, MD
1, William Boysen, MD
1, Steven L. Chang, MD
1, Douglas M. Dahl, MD
3, Eswara Jairam, MD
4, George Haleblian, MD
1, Anton Wintner, MD
3, Daniel Wollin, MD
1
1Brigham and Women's Hospital, Boston, MA, USA, 2Boston University Medical School, Boston, MA, USA, 3Massachusetts General Hospital, Boston, MA, USA, 4St. Elizabeth Medical Center Department of Urology, Brighton, MA, USA
Surgical Management of Ureteral Complications of Kidney Transplantation
Andrea Sorcini, MD, Samantha Freeman, MD, Alireza Moinzadeh, MD, Julia Hall, BA, Max S. Lohse, BA
Lahey Health, Burlington, MA, USA
The Hospital Price Transparency Rule in USNWR Ranked Hospitals- Differences in Price and Disclosure in Urologic Procedures Compared to Mammography
Anna M. Ochsner, BS, Borivoj Golijanin, BS, Justin Bessette, BS, Angelo Blancaflor, BS, Aaron Cleofas, BS, Richard Glebocki, BS, Alexandra Lee, BS, Christopher Tucci, MS, RN-BC, Elias Hyams, MD, Gyan Pareek, MD
Minimally Invasive Urology Institute, Providence, RI, USA
KSP by Degree: A Comparison of Patient Satisfaction with Counseling for Kidney Stone Prevention by Physician versus Advanced Practice Provider
Erin Santos, PA, MPH, MS
1, Loren Smith, MD
2, Evelyn James, MPH
1, Jesse D. Sammon, DO
2, David Sobel, MD
2
1Maine Medical Partners Urology, South Portland, ME, USA, 2Maine Medical Center, Portland, ME, USA
Effect of Vibegron on Quality of Life in Men with Benign Prostatic Hyperplasia and Symptoms of Overactive Bladder: Patient-Reported Outcomes From the Phase 3 Randomized Controlled COURAGE Trial
David Staskin, MD
1, Janet Owens-Grillo, PhD, MS
2, Elizabeth Thomas, MS
2, Sender Herschorn, MD
3, Kenneth Peters, MD
4, Eric S. Rovner, MD
5, Kevin Cline, MD
6, Salim Mujais, MD
2
1Tufts University School of Medicine, Boston, MA, USA, 2Sumitomo Pharma America, Inc., Marlborough, MA, USA, 3Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada, 4Oakland University William Beaumont School of Medicine, Rochester, MI, USA, 5Medical University of South Carolina, Charleston, SC, USA, 6Louisiana State University Health, Shreveport, LA, USA
Anticoagulant and Antiplatelet Medications and their Association with Hematuria-Related Complications: A Five-Year Single-Institution Retrospective Study
Joshua Hayden, MD, Jason Nelson, MPH, Edward Frankenberger, BS, Alex Vanni, MD
Lahey Hospital and Medical Center, Burlington, MA, USA
Prior Radiation Therapy is Associated with Increased Risk of Intra-Operative Complications in Patients Undergoing Primary Inflatable Penile Prosthesis Placement: Results from a Large Multi-Institutional Collaborative
Vikram S. Lyall, MD
1, Thomas Alvermann, BS
1, James Jones, MD
2, Britney Atwater, MD
1, Zafardjan Dalimov, MD
3, Linley Diao, MD
3, David Barham, MD
4, Hossein Sadeghi-Nejad, MD
5, Robert Andrianne, MD
6, Maxime Sempels, MD
6, Tung-Chin Hsieh, MD
7, Georgios Hatzichristodoulou, MD
8, Muhammad Ammad, MD
4, Daniar Osmonov, MD
9, Aaron Lentz, MD
10, Paul Perito, MD
11, Alfredo Suarez-Sarmiento, MD
11, James Hotaling, MD
12, Koenraad van Renterghem, MD
13, Sung Hun Park, MD
14, Arthur Burnett, MD
15, Jonathan Nicholas, MD
16, Martin Gross, MD
1, Faysal Yafi, MD
4, Jay Simhan, MD
3
1Dartmouth Hitchcock Medical Center, Lebanon, NH, USA, 2Boston University Medical Center, Boston, MA, USA, 3Fox Chase Cancer Center, Philadelphia, PA, USA, 4University of California Irvine, Irvine, CA, USA, 5NYU Grossman School of Medicine, New York, NY, USA, 6Centre Hospitalier Universitaire de Liege, Liege, Belgium, 7University of California, San Diego, La Jolla, CA, USA, 8'Martha-Maria' Hospital Nuremberg, Nuremberg, Germany, 9University Hospital Schleswig Holstein, Kiel, Germany, 10Duke University, Durham, NC, USA, 11Perito Urology, Coral Gables, FL, USA, 12University of Utah, Salt Lake City, UT, USA, 13Jessa Hospital, Hasselt, Belgium, 14Sewum Prosthetic Urology Center of Excellence, Seoul, Korea, Democratic People's Republic of, 15Johns Hopkins Hospital, Baltimore, MD, USA, 16Mayo Clinic, Rochester, MN, USA
The Effects of Pretreatment with Xiaflex on Penile Curvature Correction with Manual Modeling During and After IPP placement
Britney L. Atwater, MD
1, Richard H. Bellemare, MD
1, Vikram Lyall, MD
1, Thomas Alvermann, BS
1, J. Andrew Jones, MD
2, Martin S. Gross, MD
1
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 2Boston Medical Center, Boston, MA, USA
Is a Fresh Semen Analysis necessary for a Post Vasectomy Semen Analysis?: Assessment of Stability of Sperm Concentration over a 10-day Time Frame as a Model for Post Vasectomy Semen Analysis Using the Fellow System
Katherine Rotker, MD
1, Sharath Reddy, MD
1, Andrew Fernandez, CLS
2, Terri Schroeder, CLS
2, Inderpreet Kaur, CLS
2, Elsa Chen, CLS
2, Andre Belarmino, MD
3, Akanksha Mehta, MD
4, Daniel Civello, CLS
2, Stacey Kenfield, ScD
5, Stacey Kenfield, ScD
5, Daniel Nolte, MS
2, James F. Smith, MD
5, Stanton Honig, MD
1
1Yale School of Medicine, New Haven, CT, USA, 2Fellow Health, San Leandro, CA, USA, 3UCLA Medical Center, Los Angeles, CA, USA, 4Emory University, Atlanta, GA, USA, 5UCSF, San Francisco, CA, USA
Could My Men’s Health Patient be Considering Self Harm? Outpatient Urology Suicide Risk Assessment with the PHQ-9
Bethany Buckridge, RN, MSN
1, Andrew Kehm, BS
2, Ilene Staff, PhD
3, Tara McLaughlin, PhD
1, Jared Bieniek, MD
1
1Hartford HealthCare, Hartford, CT, USA, 2Frank H. Netter MD School of Medicine, North Haven, CT, USA, 3Hartford Hospital, Hartford, CT, USA
New Findings Regarding Predictors of Patient Progression to Successful Surgical Management of Idiopathic Chronic Orchialgia
Daniela Orozco Rendon, BS
1, Kathryn McGonagle, BA
1, Martin S. Gross, MD
2
1Geisel SOM at Dartmouth, Hanover, NH, USA, 2Dartmouth Health, Hanover, NH, USA
10:30 am - 11:00 am
COFFEE BREAK
11:00 am - 11:30 am
ANNUAL BUSINESS MEETING
11:30 am - 12:00 pm
LEADBETTER LECTURE
To Spare or Not to Spare: Expanding the Role of Bladder Preservation for Muscle Invasive Bladder Cancer
Cheryl T. Lee, MD
The Ohio State University, Columbus, OH
12:00 pm - 12:15 pm
RESEARCH UPDATE: The Biology of Aging
Iman Al-Naggar, PhD
University of Connecticut, Farmington, CT
Conclusion of morning accredited CME programming.
12:15 pm - 12:45 pm
PICK UP LUNCH
12:45 pm - 1:45 pm
LUNCH SYMPOSIUM
DISCOVER THE IMPACT OF GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment
Sponsored by Sumitomo Pharma America
Speaker: Jeffrey Frankel, MD Medical Director/Urologist Seattle Urology Research Center
12:45 pm - 1:45 pm
LUNCH SYMPOSIUM
PYLARIFY® (piflufolastat F 18) Injection: Injection PET Imaging in Prostate Cancer Patients: A CASE-BASED REVIEW
Sponsored by Lantheus
Speaker: Munir Ghesani, MD
1:45 pm - 2:00 pm
DEI Committee Update
Jamie Cavallo, MD
2:00 pm - 2:05 pm
Joseph B. Dowd Lifetime Achievement Award
2:05 pm - 2:15 pm
PRESIDENTIAL ADDRESS
A Look Under the Hood
Gregory Adey, MD
Fore River Urology, South Portland, ME
Afternoon accredited CME programming commences.
2:15 pm - 3:30 pm
SCIENTIFIC SESSION V: Infertility, Sexual Dysfunction and Men’s Health
(5 minute presentation, 3 minute discussion)
Moderators: Martin Kathrins, MD, Gabriella Avellino, MD
In-House Embryology Laboratories Can Prevent Bilateral MicroTESE and Improve Patient Outcomes
Sai Allu, BA
1, Rachel Greenberg, MD
2, Emily Barry, MD
2, Gabriella Avellino, MD
2, Mark Sigman, MD
2
1Warren Alpert Medical School, Providence, RI, USA, 2Brown University Department of Urology, Providence, RI, USA
Posthumous Sperm Retrieval: Survey of Knowledge of Intensive Care Unit Providers
Christopher S. Hayden, MD
1, Victoria Kong, B.S.
1, Shyoko Honiden, MD
2, Stanton Honig, MD
1, Katherine Rotker, MD
1
1Yale School of Medicine, Department of Urology, New Haven, CT, USA, 2Yale School of Medicine, Department of Medicine (Pulmonary, Critical Care and Sleep Medicine), New Haven, CT, USA
Prior Intracavernosal Injection Therapy is Associated with Intraoperative and Postoperative Complications Attributable to Poor Corporal Integrity in Patients Undergoing Inflatable Penile Prosthesis Placement
James M. Jones, MD
1, Britney Atwater, MD
2, Vikram Lyall, MD
2, Thomas Alvermann, BA
3, David Barham, MD
4, Jay Simhan, MD
5, Faysal Yafi, MD
4, Martin S. Gross, MD
2
1Boston Medical Center, Boston, MA, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 3Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 4University of California Irvine, Orange, CA, USA, 5Fox Chase Cancer Center, Philadelphia, PA, USA
Emerging Data Regarding Predictors of Patient’s Response to Spermatic Cord Block for Idiopathic Chronic Orchialgia
Daniela Orozco Rendon, BS
1, Kathryn McGonagle, BA
1, Martin S. Gross, MD
2.
1Geisel SOM at Dartmouth, Hanover, NH, USA, 2Dartmouth Health, Hanover, NH, USA
New Findings Regarding the Degree of Penile Curvature Correction with IPP Alone
Britney L. Atwater, MD
1, Richard H. Bellemare, MD
1, Thomas Alvermann, BS
1, J. Andrew Jones, MD
2, Vikram Lyall, MD
1, Martin S. Gross, MD
1
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 2Boston Medical Center, Boston, MA, USA
Differential Gene Expression in the Tunica Albuginea Tissue of Patients with and without Peyronie’s Disease
Joshua Hayden, MD, Samantha Freeman, MD, Carmen Perrino, MD, Kailey Hooper, BS, Travis Sullivan, MS, Kimberly Rieger-Christ, PhD, Alex Vanni, MD
Lahey Hospital and Medical Center, Burlington, MA, USA
Body Mass Index and Complication Profiles in Patients Undergoing Inflatable Penile Prosthesis Placement: A Large Multi-Institutional Study
Vikram S. Lyall, MD
1, Thomas Alvermann, BS
1, Britney Atwater, MD
1, Muhammad Ammad, MD
2, David Barham, MD
2, Nikolaos Pyrgidis, MD, MSc, PhD
3, Eliad Amini, MD
2, Jake Miller, MD
2, Robert Andrianne, MD
4, Hossein Sadeghi-Nejad, MD
5, Kelli Gross, MD
6, Georgios Hatzichristodoulou, MD
7, James Hotaling, MD
6, Tung-Chin Hsieh, MD
8, Aaron Lentz, MD
9, Vaibhav Modgil, MD
10, Daniar Osmonov, MD
11, Sung Hun Park, MD
12, Faysal Yafi, MD
2, Paul Perito, MD
13, Jay Simhan, MD
14, Koenraad van Renterghem, MD
15, Martin Gross, MD
1.
1Dartmouth Hitchcock Medical Center, Lebanon, NH, USA, 2University of California Irvine, Irvine, CA, USA, 3Ludwig-Maximilians-University of Munich, Munich, Germany, 4Centre Hospitalier Universitaire de Liege, Liege, Belgium, 5NYU Grossman School of Medicine, New York, NY, USA, 6University of Utah, Salt Lake City, UT, USA, 7'Martha-Maria' Hospital Nuremberg, Nuremberg, Germany, 8University of California, San Diego, La Jolla, CA, USA, 9Duke University, Durham, NC, USA, 10Manchester Andrology Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom, 11University Hospital Schleswig Holstein, Kiel, Germany, 12Sewum Prosthetic Urology Center of Excellence, Seoul, Korea, Democratic People's Republic of, 13Perito Urology, Coral Gables, FL, USA, 14Fox Chase Cancer Center, Philadelphia, PA, USA, 15Jessa Hospital, Hasselt, Belgium
Mail-In Semen Analysis Vs Fresh Sample For Post-Vasectomy Semen Analysis (PVSA): Identifying An Efficient Approach To Achieving Post-Vasectomy Clearance
Katherine Rotker, MD
1, Daniel Nolte, MS
2, Stacey A. Kenfield, ScD
3, Andre Belarmino, MD
4, Daniel Civello, BS
2, James F. Smith, MD
2, Stanton Honig, MD
5
1Yale School of Medicine, New London, CT, USA, 2Fellow Health, San Leandro, CA, USA, 3University of California San Francisco, San Francisco, CA, USA, 4UCLA Medical Center, Los Angeles, CA, USA, 5Yale School of Medicine, New Haven, CT, USA
2:15 pm - 3:30 pm
CONCURRENT RESIDENT QUIZ BOWL
Facilitator: Michael T. Grant, MD
3:30 pm - 4:00 pm
COFFEE BREAK
4:00 pm - 4:30 pm
SUO Lecture: A Personalized and Pragmatic Approach to Prehabilitation
Sarah Psutka, MD, MSc
University of Washington, Seattle, WA
Conclusion of afternoon accredited CME programming.
4:30 pm - 5:15 pm
YOUNG UROLOGIST FORUM: Defining Early Career “Success”
Moderator: Phil Olson, MD
Panel Discussion (25 min)
Academic Practice
Jamie Cavallo, MD
Yale Medicine
Healthcare System Employed (affiliated with residency)
Jared Bieniek, MD
Hartford Healthcare
Other
Joseph McQuaid, MD, MBA
Aura Bio Sciences
EMR Efficiency: Tips and Tricks (20 min)
David Canes, MD
6:30 pm - 9:30 pm
PRESIDENTIAL CELEBRATION
The Graduate Hotel
SATURDAY, SEPTEMBER 7, 2024
7:00 am - 8:00 am
CONTINENTAL BREAKFAST
Morning accredited CME programming commences.
7:00 AM - 7:30 AM
Networking Breakfast
7:30 AM - 7:50 AM
Prostate Cancer Screening and diagnosis for the APP
Presenter: Erin Santos, PA-C
7:50 AM - 8:10 AM
Urethral Stricture Update for APP
Presenter: Alex Vanni, MD
8:10 AM - 8:30AM
Urodynamics: Introduction
Presenter: Joel Lee, PA-C
8:30 AM - 8:50 AM
Transgender Care for the APP
Presenter: Khushabu Kasabwala, MD
9:00 AM - 10:00 AM
Sex Therapist
Presenter: Michele Waldron, Psy.D, LADC-I, CSCT
8:00 am - 9:30 am
SCIENTIFIC SESSION VI: Bladder/Kidney Cancer
(5 minute presentation, 3 minute discussion)
Moderators: Matthew Hayn, MD
Patrick Kenney, MD
TAR-200 in Patients With Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the SunRISe-1 Study
Joseph Jacob, MD
1, Andrea Necchi, MD
2, Siamak Daneshmand, MD
3, Giuseppe Simone, MD
4, Evanguelos Xylinas, MD
5, David S. Morris, MD
6, Philipp Spiegelhalder, MD
7, Daniel Zainfeld, MD
8, Taek Won Kang, MD
9, Justin T. Matulay, MD
10, Laurence H. Belkoff, MD
11, Karel Decaestecker, MD
12, Harm Arentsen, MD
13, Shalaka Hampras, PhD
14, Chrsitopher J. Cutie, MD
15, Hussein Sweiti, MD
16, Katharine Stromberg, PhD
14, Jason Martin, MD
17, Abhijit Shukla, MD
15, Michiel S. van der Heijden, MD
18
1Department of Urology, Upstate Medical University, Syracuse, NY, USA, 2IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Mialn, Italy, 3Department of Urology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA, 4Department of Urology, 'Regina Elena' National Cancer Institute, Rome, Italy, 5Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris Cité, Paris, France, 6Urology Associates, Nashville, TN, USA, 7Urologie Neandertal, Gemeinschaftspraxis für Urologie, Mettmann, Germany, 8Urology San Antonio, San Antonio, TX, USA, 9Department of Urology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, Korea, Republic of, 10Atrium Health Levine Cancer Institute, Charloette, NC, USA, 11MidLantic Urology/Solaris Health, Bala Cynwyd, PA, USA, 12Department of Urology, AZ Maria Middelares, Ghent, Belgium, 13AZ Sint-Jan Hospital Brugge-Oostende, Bruges, Belgium, 14Janssen Research & Development, Raritan, NJ, USA, 15Janssen Research & Development, Lexington, MA, USA, 16Janssen Research & Development, Spring House, PA, USA, 17Janssen Research & Development, High Wycombe, United Kingdom, 18Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands
Genomic Profiling of Young Bladder Cancer Patients Undergoing Radical Cystectomy Highlights KMT2D Enrichment
Christopher J. Magnani, MD MS, Phil, Vincent D'Andrea, MD, Kendrick Yim, MD, Zhiyu (Jason) Qian, MD, Nnamdi Onochie, BS, Benjamin V. Stone, MD, Jillian Egan, MD, Adam S. Kibel, MD, Mark A. Preston, MD, Steven L. Chang, MD MS, Matthew Mossanen, MD, Filipe L.F. Carvalho, MD PhD, Timothy N. Clinton, MD
Brigham and Women's Hospital, Boston, MA, USA
Real-World, Contemporary Efficacy of Immediate Postoperative Chemotherapy Following Transurethral Resection of Bladder Tumor in Older Adults
Andrew Amini, BS
1, Sumedh Kaul, MS
2, Aaron Fleishman, MPH
2, Agustin Perez, MD
3, Ruslan Korets, MD
3, Peter Chang, MD
3, Andrew Wagner, MD
3, Simon Kim, MD
4, Joaquim Bellmunt, MD
5, Nima Aghdam, MD
6, Aria F. Olumi, MD
3, Boris Gershman, MD
3
1Department of Urology, Massachusetts General Hospital, Boston, MA, USA, 2Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA, 3Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA, 4Division of Urologic Surgery, University of Colorado Anschutz Medical Center, Aurora, CO, USA, 5Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA, 6Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA
Real-World Treatments Following Bacillus Calmette-Guérin Induction In Patients With Non-Muscle-Invasive Bladder Cancer: A Contemporary Us Claims Analysis
Min Yang, PhD, MS
1, Mirko Fillbrunn, PhD
1, Hesen Li, PhD
1, Adina Zhang, MS
1, Zhou Chen, MPH
1, Ashton Moradi, MS
2, Amy Guo, PhD
2, Ashish M. Kamat, MD
3
1Analysis Group, Inc., Boston, MA, USA, 2Ferring Pharmaceuticals Inc., Parsippany, NJ, USA, 3University of Texas MD Anderson Cancer Center, Houston, TX, USA
Efficacy Of Intravesical Nadofaragene Firadenovec-Vncg For Patients With Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: 36-Month Follow-Up From A Phase 3 Trial
Leonard G. Gomella, MD
1, Stephen A. Boorjian, MD
2, Vikram M. Narayan, MD
3, Badrinath R. Konety, MD
4, Viraj A. Master, MD, PhD
3, Neal D. Shore, MD
5, Ashish M. Kamat, MD
6, Trinity J. Bivalacqua, MD, PhD
7, Max R. Kates, MD
8, Jeffrey S. Montgomery, MD
9, Paul L. Crispen, MD
10, Gary D. Steinberg, MD
11, Piyush K. Agarwal, MD
12, Anne Schuckman, MD
13, Lawrence I. Karsh, MD, FACS
14, Marc A. Bjurlin, DO, MSc, FACOS
15, Gordon A. Brown, DO
16, Yair Lotan, MD
17, Brant A. Inman, MD
18, Michael B. Williams, MD
19, Michael S. Cookson, MD, FACS
20, Sam S. Chang, MD, MBA
21, Eric H. Kim, MD
22, Alexander I. Sankin, MD
23, Colin P N Dinney, MD
6
1Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA, 2Mayo Clinic, Rochester, MN, USA, 3Emory University School of Medicine, Atlanta, GA, USA, 4University of Minnesota and Allina Health Cancer Institute, Minneapolis, MN, USA, 5Carolina Urologic Research Center, Myrtle Beach, SC, USA, 6University of Texas MD Anderson Cancer Center, Houston, TX, USA, 7University of Pennsylvania, Philadelphia, PA, USA, 8The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA, 9University of Michigan, Ann Arbor, MI, USA, 10University of Florida, Gainesville, FL, USA, 11Rush University, Chicago, IL, USA, 12University of Chicago, Chicago, IL, USA, 13USC Institute of Urology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA, 14The Urology Center of Colorado, Denver, CO, USA, 15University of North Carolina, Chapel Hill, NC, USA, 16New Jersey Urology, Cherry Hill, NJ, USA, 17University of Texas Southwestern Medical Center, Dallas, TX, USA, 18Schulich School of Medicine & Dentistry, Western University, London, ON, Canada, 19Urology of Virginia, Virginia Beach, VA, USA, 20University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA, 21Vanderbilt University, Nashville, TN, USA, 22Siteman Cancer Center Barnes-Jewish Hospital, Washington University School of Medicine, Saint Louis, MO, USA, 23Montefiore Medical Center, Bronx, NY, USA
Patterns and Frequency of Synoptic Bladder & Kidney Cancer Reporting in VA Medical Centers: A Nationwide Study
Soham Kale, BS
1, Abdol Aziz Ould Ismail, MD
1, Kathryn McGonagle, BS
1, Brent Hill, MD
2, Jason R. Pettus, MD
3, Scott L. DuVall, MD
2, Jeffrey P. Ferraro, MD
2, Florian Schroeck, MD, MS
1
1White River Junction VA Healthcare System, White River Junction, VT, USA, 2Salt Lake City VA Healthcare System, Salt Lake City, UT, USA, 3Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
Prospective Health-Related Quality of Life in Women undergoing Radical Cystectomy and Urinary Diversion
Matthew B. Clements, MD, MS
1, Kelly Pekala, MD
2, Daniel Sjoberg, MS
2, Thomas Atkinson, PhD
2, Guido Dalbagni, MD
2, Andrew Vickers, PhD
2, Harry Herr, MD
2, S Machele Donat, MD
2, Amy Tin, MS
2, Bernard Bochner, MD
2
1Lahey Hospital & Medical Center, Burlington, MA, USA, 2Memorial Sloan Kettering Cancer Center, New York, NY, USA
Evaluation of the NSQIP Surgical Risk Calculator Relative to Observed Outcomes Following Radical Cystectomy
Loren J. Smith, MD
1, Randie White, MD
1, Connor Pelletier, B.S.
2, Evelyn James, MPH
1, Joshua Linscott, MD, PhD
3, Jeffrey Howard, MD, PhD
1, Stephen T. Ryan, MD
1, Matthew T. Hayn, MD
1, Jesse D. Sammon, D.O.
1
1Department of Urologic Surgery, Maine Medical Center, Portland, ME, USA, 2University of New England, Portland, ME, USA, 3Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA
Adjuvant Chemotherapy versus Observation for Locally Advanced Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy
Sina Monfared, MD
1, Sumedh Kaul, MS
1, Aason Fleishman, MPH
1, Agustin Perez, MD
1, Ruslan Korets, MD
1, Peter Chang, MD
1, Andrew Wagner, MD
1, Simon Kim, MD
2, Joaquim Bellmunt, MD, PhD
1, Nima Aghdam, MD
1, Aria Olumi, MD
1, Boris Gershman, MD
1
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2University of Colorado, Aurora, CO, USA
Association Between Time from Diagnosis to Radical Cystectomy and Oncologic Outcomes for Muscle-Invasive Urothelial Carcinoma of the Bladder
Phillip Kim, MD
1, Sumedh Kaul, MS
1, Aaron Fleishman, MPH
1, Agustin Perez, MD
1, Simon Kim, MD
2, Joaquim Bellmunt, MD
3, Nima Aghdam, MD
1, Aria Olumi, MD
1, Peter Chang, MD
1, Andrew Wagner, MD
1, Boris Gershman, MD
1
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2University of Colorado, Aurora, CO, USA, 3Dana Farber Cancer Institute, Boston, MA, USA
Exploring Recurrence After Initial Response to UGN-101 Induction in Expanded Settings
Adam S. Feldman, MD, MPH
1, Solomon Woldu, MD
2, Brett Johnson, MD
2, Katie Murray, DO
3, Hiroko Miyagi, MD
4, Wade Sexton, MD
4, Isamu Tachibana, MD
5, Hristos Kaimakliotis, MD
5, Joseph Jacob, MD
6, Rian Dickstein, MD
7, Jennifer Linehan, MD
8, Alan Nieder, MD
9, Marc Bjurlin, MD
10, Daniel Hidenberg, MD
11, Mitchell Humprheys, MD
11, Saum Ghodoussipor, MD
12, Marcus Quek, MD
13, Michael O'Donnell, MD
14, Brian Eisner, MD
1, Yair Lotan, MD
2, Surena Matin, MD
15
1Massachusetts General Hospital, Boston, MA, USA, 2UT Southwestern, Dallas, TX, USA, 3New York University, New York, NY, USA, 4Moffitt Cancer Center, Tampa, FL, USA, 5Indiana University Medical Center, Indianapolis, IN, USA, 6State University of New York Upstate Medical Center, Syracuse, NY, USA, 7University of Maryland Medical Center, Baltimore, MD, USA, 8Providence Specialty Medical Group, Santa Monica, CA, USA, 9Mount Sinai Medical Center, Miami Beach, FL, USA, 10University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 11Mayo Clinic Cancer Center, Phoenix, AZ, USA, 12Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA, 13Loyola University Medical Center, Maywood, IL, USA, 14University of Iowa Health Care, Iowa City, IA, USA, 15University of Texas MD Anderson Cancer Center, Houston, TX, USA
9:30 am - 10:00 am
COFFEE BREAK
10:00 AM - 10:30 AM
STATE OF THE ART LECTURE II: AI in Healthcare: Practical Applications and Emerging Opportunities
Anobel Odisho, MD, MPH
University of California San Francisco, San Francisco, CA
10:30 AM - 11:45 AM
Achieving and Sustaining Peak Performance: Strategies for Doctors and Their Teams
10:30 AM - 11:00 AM
Kevin Nylen
Head Coach, Boston University Men's Soccer
11:00 AM - 11:10 AM
John Pawlowski, MD
Beth Israel Deaconess Medical Center, Boston, MA
11:10 AM - 11:20 AM
Dan Wollin, MD
Brigham and Women's Hospital, Boston, MA
11:20 - 11:30 AM
Sarah Psutka, MD, MSc
University of Washington, Seattle, WA
11:30 - 11:45 AM
Discussion
11:30 am - 12:30 pm
SCIENTIFIC SESSION VII: Prostate Cancer II
(5 minute presentation, 3 minute discussion)
Moderators: Preston Sprenkle, MD, Matthew Mossanen, MD
Changes In Prostate Cancer Diagnostic Treatment Services Among Medicare Beneficiaries Associated With The COVID Pandemic
Vinaik Mootha Sundaresan, B.S.
1, Shayan Smani, B.S.
1, Victoria Kong, B.S.
1, Ryan Sutherland, B.S., MPH
1, Ryan Antar, B.S.
2, Jeffrey Weinreb, MD
1, Jay K. Pahade, MD
1, Sandeep Arora, MBBS
1, Isaac Y. Kim, MD, PhD, MBA
1, Joseph Renzulli, MD
1, Preston Sprenkle, MD
1, Christopher Filson, MD, MS
3, Michael S. Leapman, MD, MHS
1
1Yale School of Medicine, New Haven, CT, USA, 2George Washington School of Medicine, Washington, DC, USA, 3Kaiser Permanente, Los Angeles, CA, USA
Changes in Serial Decipher Genomic Classifier Testing Among Patients with Prostate Cancer Managed with Active Surveillance
Lindsey T. Webb, BSME, Ghazal Khajir, MD, Darryl T. Martin, PhD, Nethusan Sivanesen, BS, BA, Gabriela M. Diaz, MD, Michael S. Leapman, MD, Isaac Y. Kim, MD, PhD, Preston C. Sprenkle, MD.
Yale School of Medicine, New Haven, CT, USA.
Patient Demographic Factors Associated with Radiation Cystitis Development Following Radiation for Prostate Cancer
Remington T. Lim, MD
1, Ernie Shippey, MS
2, Andrew P. Loehrer, MD, MPH
1, Lawrence M. Dagrosa, MD
1, Jay C. Buckey Jr., MD
1, Rachel A. Moses, MD, MPH
1.
1Dartmouth Health, Lebanon, NH, USA, 2Vizient Center for Advanced Analytics, Chicago, IL, USA.
Treatment of Mixed Urinary Incontinence After Radical Treatment of Prostate Cancer with Botulinum Toxin: Can Surgery for Stress Incontinence be Avoided in Some Patients?
Philip Olson, MD
1, Dylan Buller, MD
1, Ilene Staff, PhD
2, Tara McLaughlin, PhD
2, Joseph Tortora, MS
2, Kevin Pinto, BS
2, Laura Olivo Valentin, BS
2, Richard Kershen, MD
3.
1UConn Health, Farmington, CT, USA, 2Hartford Healthcare, Hartford, CT, USA, 3Hartford Healthcare Medical Group, Hartford, CT, USA.
Body Mass Index Trajectory in Men on Active Surveillance for Prostate Cancer
Dylan Buller, MD
1, Alexander Bandin, MD
2, Ilene Staff, PhD
2, Tara McLaughlin, PhD
2, Joseph Tortora, MS
2, Kevin Pinto, BS
2, Joseph Wagner, MD
3.
1UConn Health, Farmington, CT, USA, 2Hartford Healthcare, Hartford, CT, USA, 3Hartford Healthcare Medical Group, Hartford, CT, USA.
Does a Positive Fluoroquinolone Resistant Rectal Swab Prior to Transrectal Prostate Biopsy Predict Post-Biopsy Infection in a Large, Multi-Center Institution?
Maximilian James Rabil, MD, Ankur U. Choksi, MD, Soum D. Lokeshwar, MD, M.B.A., Syed Rahman, MD, Preston Sprenkle, MD, Michael S. Leapman, MD, M.H.S., Joseph Renzulli, MD, Joseph Brito, III, MD.
Yale University School of Medicine, New Haven, CT, USA.
Can AI Be Useful as A Clinical Tool for Risk Stratifying Localized Prostate Cancer Patients?
Randie E. White, MD
1, Jaqueline Klepinger, BS
2, Jeffrey M. Howard, MD, PhD
1, Jesse D. Sammon, DO
1, Matthew H. Hayn, MD
1, Stephen T. Ryan, MD
1.
1Maine Medical Center, PORTLAND, ME, USA, 2University of New England School of Osteopathic Medicine, Biddeford, ME, USA
Conclusion of afternoon accredited CME programming.